zur Navigation zum Inhalt
Onkologie 13. Jänner 2016

American Society of Clinical Oncology annual meeting 2015

The annual meeting of the American Society of Clinical Oncology represents the yearly highlight for the world-wide oncologic community. This year saw around 30,000 participants convening in Chicago where they were presented with a wealth of new data.

This years’ motto was “Illumination and Innovation, transforming data into learning”. The hot topics 2015 were the immune-checkpoint-inhibitor therapies especially in malignant melanoma and non-small-cell-lung cancer (NSCLC) as will be high-lighted by Georg Pall. In a subgroup of patients with NSCLC, this new treatment was so effective that it replaced docetaxel as second-line therapy after a first-line regimen including a platinum.

Zu diesem Thema wurden noch keine Kommentare abgegeben.

Mehr zum Thema

<< Seite 1 >>

Medizin heute

Aktuelle Printausgaben